Lv44
560 积分 2023-12-12 加入
Generation of membrane-permeable cyclic peptides inhibiting protein–protein interaction
7天前
已完结
Macrocyclic peptides as protein–protein interaction modulators: a review
7天前
已完结
Discovery and development of small-molecule inhibitors targeting cytotoxic T lymphocyte associated protein 4 to enhance cancer immunotherapy and reduce side effects
27天前
已完结
BPS2026 – A systematic framework for peptide-based inhibition of SHP2 protein-protein interactions
27天前
已关闭
The SHERPA trial: A phase I study combining SHP2 inhibitor RMC-4630 and ERK inhibitor LY3214996 in patients with KRAS-mutant pancreatic, non-small cell lung and colorectal cancer
28天前
已完结
Discovery of JAB-3312, a Potent SHP2 Allosteric Inhibitor for Cancer Treatment
28天前
已完结
Design of cyclic peptides as novel inhibitors of ICOS/ICOSL interaction
30天前
已完结
Computational Design of a Bicyclic Peptide Inhibitor Targeting the ICOS/ICOS-L Protein–Protein Interaction
30天前
已完结
OX40 and OX40L Interaction in Cancer
1个月前
已完结
Costimulatory connections: CARMIL2 and CD28
1个月前
已完结
皖公网安备34019202002308
